Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 14, 2014; 20(26): 8535-8544
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8535
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8535
Table 1 Demographics and clinical characteristics of 153 patients n (%)
Characteristic | Value |
Age (yr), mean (range) | 65.2 (28-89) |
Male/female | 101/52 |
Preoperative symptom(s) | 37 (24) |
Diabetes mellitus (preoperative ) | 39 (25) |
History of pancreatitis | 20 (13) |
Body mass index, mean ± SD | 22.5 ± 3.5 |
Procedure | |
Pancreatoduodenectomy | 103 |
Distal pancreatectomy | 50 |
Resection of the portal vein | 21 (14) |
Pathological diagnosis | |
Invasive carcinoma of the pancreas | 68 |
Intraductal papillary mucinous neoplasm | 35 |
Carcinoma of the ampulla | 13 |
Cholangiocarcinoma | 10 |
Pancreatic neuroendocrine tumor | 8 |
Other | 19 |
Grade of postoperative pancreatic fistula1 | |
A | 76 |
B | 70 |
C | 7 |
Table 2 Inflammatory markers for clinically relevant postoperative pancreatic fistulas
Marker | POD 1 | POD 3 | POD 5 | Change from POD 1 to 3 | Change from POD 3 to 5 | |||||||
AUC | P value | AUC | P value | Cutoff | AUC | P value | AUC | P value | Cutoff | AUC | P value | |
White blood cell count (/mm3) | 0.545 | 0.343 | 0.524 | 0.615 | 11400 | 0.588 | 0.067 | 0.504 | 0.939 | 600 | 0.557 | 0.242 |
Neutrophil count (/mm3) | 0.560 | 0.198 | 0.532 | 0.495 | 8200 | 0.591 | 0.060 | 0.506 | 0.898 | -3300 | 0.560 | 0.215 |
Total lymphocyte count (/mm3) | 0.524 | 0.604 | 0.577 | 0.097 | 600 | 0.541 | 0.397 | 0.550 | 0.285 | 0 | 0.518 | 0.708 |
Platelet count (/mm3) | 0.540 | 0.399 | 0.615 | 0.014 | 164000 | 0.580 | 0.098 | 0.603 | 0.028 | -24000 | 0.549 | 0.310 |
Serum amylase (IU/mL) | 0.504 | 0.935 | 0.580 | 0.087 | 136 | 0.600 | 0.039 | 0.502 | 0.966 | -69 | 0.522 | 0.643 |
C-reactive protein (mg/L) | 0.534 | 0.532 | 0.688 | < 0.001 | 158 | 0.684 | < 0.001 | 0.767 | < 0.001 | 28.4 | 0.565 | 0.200 |
Procalcitonin (ng/mL) | - | - | 0.584 | 0.451 | 0.3 | - | - | - | - | - | - | - |
Neutrophil-to-lymphocyte ratio | 0.532 | 0.497 | 0.579 | 0.092 | 9.6 | 0.590 | 0.061 | 0.537 | 0.433 | -0.3 | 0.558 | 0.420 |
Platelet to lymphocyte ratio | 0.517 | 0.718 | 0.529 | 0.557 | 231 | 0.557 | 0.243 | 0.508 | 0.858 | 67 | 0.539 | 0.231 |
Table 3 Diagnostic value of clinical factors for clinically relevant postoperative pancreatic fistula
Variable | Univariate | Multivariable | ||||
Odds ratio | 95%CI | P value | Odds ratio | 95%CI | P value | |
Age (≥ 65 yr) | 1.16 | 0.61-2.23 | 0.654 | |||
Gender (male) | 1.29 | 0.66-2.53 | 0.459 | |||
Diabetes mellitus | 1.39 | 0.67-2.92 | 0.378 | |||
History of pancreatitis | 0.62 | 0.23-1.59 | 0.321 | |||
Body mass index (≥ 22) | 1.48 | 0.79-2.82 | 0.226 | |||
Operative procedure (DP) | 1.65 | 0.83-3.28 | 0.151 | |||
Invasive carcinoma of the pancreas | 2.31 | 1.21-4.47 | 0.011 | 2.94 | 1.08-8.55 | 0.035 |
Operative time (≥ 360 min) | 1.33 | 0.71-2.53 | 0.376 | |||
Blood loss (≥ 600 mL) | 1.83 | 0.97-3.51 | 0.063 | 1.73 | 0.62-4.86 | 0.297 |
Intraoperative transfusion | 1.45 | 0.48-4.59 | 0.511 | |||
Pancreas texture (soft) | 1.46 | 0.69-3.10 | 0.322 | |||
Main pancreatic duct (< 4 mm) | 1.36 | 0.70-2.65 | 0.366 | |||
Persistence of high fever (≥ 38 °C, ≥ 3 d) | 1.10 | 0.57-2.14 | 0.781 | |||
Persistence of SIRS (≥ 3 d) | 1.68 | 0.88-3.23 | 0.116 | |||
Usage of catecholamines | 1.73 | 0.68-4.62 | 0.251 | |||
Total lymphocyte count (< 600/mm3, POD 3) | 1.73 | 0.74-4.23 | 0.201 | |||
Platelet count (< 164000/mm3, POD 3) | 2.28 | 1.20-4.39 | 0.012 | 1.28 | 0.44-3.64 | 0.646 |
CRP (≥ 158 mg/L, POD 3) | 4.82 | 2.37-10.2 | < 0.001 | 2.39 | 0.73-8.03 | 0.150 |
Neutrophil-to-lymphocyte ratio (≥ 9.6, POD 3) | 1.84 | 0.97-3.52 | 0.061 | 1.56 | 0.55-4.40 | 0.401 |
CRP elevation (≥ 28.4 mg/L, POD 1 to 3) | 11.4 | 4.35-34.3 | < 0.001 | 4.82 | 1.25-20.2 | 0.022 |
Drain amylase (≥ 1918 IU/mL, POD 3) | 3.00 | 1.57-5.86 | 0.001 | 1.50 | 0.55-4.08 | 0.423 |
Drain fluid bacterial culture (positive, POD 3) | 1.62 | 0.68-3.87 | 0.278 |
Table 4 Comparison of diagnostic performance of potent factors for clinically relevant postoperative pancreatic fistula
Odds ratio | 95%CI | P value | Sensitivity | Specificity | Positive predictive value | Negative predictive value | Likelihood ratio of positive result | Likelihood ratio of negative result | |
CRP ≥ 158 mg/L1 | 4.82 | 2.37-10.2 | < 0.001 | 0.594 | 0.767 | 0.707 | 0.667 | 2.552 | 0.529 |
CRP elevation ≥ 28.4 mg/L2 | 11.4 | 4.35-34.3 | < 0.001 | 0.864 | 0.643 | 0.655 | 0.857 | 2.418 | 0.212 |
Drain amylase ≥ 1918 IU/mL1 | 3.00 | 1.57-5.86 | 0.001 | 0.636 | 0.632 | 0.636 | 0.632 | 1.727 | 0.576 |
Risk score ≥ 8 | 12.9 | 5.13-35.4 | < 0.001 | 0.795 | 0.768 | 0.729 | 0.827 | 3.427 | 0.266 |
- Citation: Kanda M, Fujii T, Takami H, Suenaga M, Inokawa Y, Yamada S, Kobayashi D, Tanaka C, Sugimoto H, Koike M, Nomoto S, Fujiwara M, Kodera Y. Novel diagnostics for aggravating pancreatic fistulas at the acute phase after pancreatectomy. World J Gastroenterol 2014; 20(26): 8535-8544
- URL: https://www.wjgnet.com/1007-9327/full/v20/i26/8535.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i26.8535